Concepedia

Thomas McQuaid

TM

3

Publications

404

Citations

3

H-Index

1994

Active since

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Thomas McQuaid is an author at Vertex Pharmaceuticals (United States) specializing in medicine, tumor microenvironment, and molecular neuroscience.

ORCID

Top concepts

Publications per year

1994–2000

3

Publications

3

Broad-Spectrum Antiviral Activity of the IMP Dehydrogenase Inhibitor VX-497: a Comparison with Ribavirin and Demonstration of Antiviral Additivity with Alpha Interferon

William Markland, Thomas McQuaid, Jugnu Jain et al. · Antimicrobial Agents and Chemotherapy · 2000 · 253 citations · Full text

The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes.

Mina Yaar, Mark S. Eller, P. DiBenedetto et al. · Journal of Clinical Investigation · 1994 · 126 citations · Full text

, , +23

Purification and characterization of the NS3 serine protease domain of hepatitis C virus expressed in Saccharomyces cerevisiae.

William Markland, Margaret Fitzgibbon, Ted Fox et al. · Journal of General Virology · 1997 · 25 citations

, , +16

Rows per page

1–3 of 3